Michael Allen

Senior Lecturer

Griffith University

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Cancer Biology Cancer Biology professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Michael Allen is a Senior Lecturer at Griffith University in Australia. His research focuses on oncology, with particular interest in treatment outcomes for pancreatic adenocarcinoma, metastatic esophageal and gastric carcinoma, and the prognostic impacts of various clinical features. Dr. Allen has contributed to multiple recent publications that explore patient survival predictions and the efficacy of therapeutic approaches in advanced cancer cases.

Articles (10)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (5)

Jaeseung Kim

Assistant Professor

Michigan Medicine

UNITED STATES

View details

Osvaldo Espin-Garcia

Assistant Professor

Western University

CANADA

View details

Jonathan Yeung

Assistant Professor

University of Toronto

CANADA

View details

Rebecca KS Wong

CANADA

View details

George Zogopoulos

McGill University

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michael Allen

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Treatment and Survival for Unresectable Pancreatic Adenocarcinoma in Queensland, Australia, 2018–2022

Outcomes in older adults with metastatic esophageal and gastric carcinoma treated with palliative chemotherapy

Comparison of Four Clinical Prognostic Scores in Patients with Advanced Gastric and Esophageal Cancer

Systemic inflammatory prognostic scores in advanced pancreatic adenocarcinoma.

First impressions: A prospective evaluation of patient–physician concordance and satisfaction following the initial medical oncology consultation

Combination of clinical, radiomic, and “delta” radiomic features in survival prediction of metastatic gastroesophageal adenocarcinoma

hENT1 Expression Predicts Response to Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Ductal Adenocarcinoma

Dosing, efficacy and safety of lenvatinb in the real‐world treatment of hepatocellular carcinoma: Results from a Canadian database

Combined 18F-FDG PET/CT Radiomics and Sarcopenia Score in Predicting Relapse-Free Survival and Overall Survival in Patients With Esophagogastric Cancer

Molecular characterisation of pancreatic ductal adenocarcinoma with <i>NTRK</i> fusions and review of the literature.

Collaborators (5)

Jaeseung Kim

Osvaldo Espin-Garcia

Jonathan Yeung

Rebecca KS Wong

George Zogopoulos

Make your next move.